683 Capital Management’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-27,000
| Closed | -$186K | – | 264 |
|
|
2023
Q1 | $186K | Sell |
27,000
-63,000
| -70% | -$435K | 0.01% | 141 |
|
|
2022
Q4 | $358K | Sell |
90,000
-885,000
| -91% | -$3.52M | 0.03% | 121 |
|
|
2022
Q3 | $6.48M | Sell |
975,000
-925,000
| -49% | -$6.15M | 0.5% | 55 |
|
|
2022
Q2 | $9.2M | Sell |
1,900,000
-32,829
| -2% | -$159K | 0.65% | 50 |
|
|
2022
Q1 | $18.1M | Hold |
1,932,829
| – | – | 0.97% | 27 |
|
|
2021
Q4 | $23M | Buy |
1,932,829
+2,900
| +0.2% | +$34.5K | 0.84% | 21 |
|
|
2021
Q3 | $22M | Hold |
1,929,929
| – | – | 0.86% | 24 |
|
|
2021
Q2 | $34.6M | Buy |
1,929,929
+36,529
| +2% | +$655K | 1.2% | 12 |
|
|
2021
Q1 | $29.3M | Buy |
1,893,400
+72,251
| +4% | +$1.12M | 1.55% | 15 |
|
|
2020
Q4 | $22.2M | Buy |
1,821,149
+849,431
| +87% | +$10.4M | 1.05% | 16 |
|
|
2020
Q3 | $12.5M | Buy |
971,718
+740,372
| +320% | +$9.51M | 0.91% | 20 |
|
|
2020
Q2 | $2.35M | Hold |
231,346
| – | – | 0.19% | 63 |
|
|
2020
Q1 | $1.88M | Hold |
231,346
| – | – | 0.22% | 59 |
|
|
2019
Q4 | $2M | Sell |
231,346
-43,654
| -16% | -$377K | 0.23% | 49 |
|
|
2019
Q3 | $1.7M | Sell |
275,000
-75,000
| -21% | -$462K | 0.19% | 53 |
|
|
2019
Q2 | $5.81M | Hold |
350,000
| – | – | 0.53% | 33 |
|
|
2019
Q1 | $5.85M | Buy |
350,000
+12,500
| +4% | +$209K | 0.53% | 32 |
|
|
2018
Q4 | $3.88M | Buy |
337,500
+62,500
| +23% | +$718K | 0.23% | 39 |
|
|
2018
Q3 | $11M | Sell |
275,000
-25,000
| -8% | -$1M | 0.71% | 21 |
|
|
2018
Q2 | $8.48M | Hold |
300,000
| – | – | 0.57% | 24 |
|
|
2018
Q1 | $4.58M | Buy |
300,000
+162,500
| +118% | +$2.48M | 0.41% | 38 |
|
|
2017
Q4 | $4.49M | Buy |
+137,500
| New | +$4.49M | 0.38% | 47 |
|